CLBT — Cellebrite DI Ltd.

Summary of Cellebrite DI Ltd. Q3 2025 Earnings Call

1. Key Financial Results and Metrics

• Annual Recurring Revenue (ARR): Grew 19% year-over-year to $440 million, with a sequential increase of 5%.
• Revenue: Reported at $126 million, an 18% increase from the prior year, driven primarily by a 21% growth in subscription revenue, which constitutes 89% of total revenue.
• Gross Profit: Increased to $106.5 million, resulting in a gross margin of 84.5%.
• Adjusted EBITDA: Rose 20% year-over-year to $37.7 million, with an adjusted EBITDA margin of 29.9%.
• Net Income: Reported at $36.9 million, or $0.14 per diluted share.
• Free Cash Flow: Generated $30 million in Q3, with a trailing twelve-month free cash flow of $140 million, equating to a 31% margin.

2. Strategic Updates and Business Highlights

• Product Adoption: Approximately 47% of the installed digital forensics license base has been converted to the insights offering, with a target of 50% by the end of 2025.
• Cloud and SaaS Growth: ARR for cloud and SaaS solutions grew three times faster than total ARR, with the Guardian platform seeing significant adoption.
• Federal Segment: Experienced year-over-year growth, with several marquee clients added, although full normalization is expected in 2026.
• Keryllium Acquisition: Anticipated to close soon, expected to enhance offerings in the defense and intelligence sectors.
• Focus Areas: Emphasis on expanding unlock and access solutions, accelerating AI innovation, and enhancing cloud capabilities.

3. Forward Guidance and Outlook

• Q4 2025 ARR Growth: Expected to grow sequentially in the mid-single digits.
• Full-Year 2025 Revenue Guidance: Maintained at $460 million to $475 million, reflecting traditional seasonality.
• Adjusted EBITDA Guidance: Increased midpoint to $124 million to $127 million for 2025.
• 2026 Outlook: Anticipated growth acceleration, but specific guidance will be provided in February 2026.

4. Bad News, Challenges, or Points of Concern

• Federal Segment Headwinds: While growth was seen in Q3, the company remains cautious about the fourth quarter due to normal government seasonality and recent shutdowns.
• Keryllium Acquisition Risks: Potential delays due to CFIUS review processes, although management is optimistic about closing soon.
• Competitive Landscape: While the company feels secure in its position, ongoing competition and the emergence of AI entrants could pose future challenges.

5. Notable Q&A Insights

• Cloud Adoption: Management is actively working with customers on transitioning to cloud solutions, with a proactive approach to support.
• Keryllium Pipeline: A significant pipeline has been established, with expectations for future transactions post-acquisition.
• Federal Growth Contributions: Growth in the federal segment was attributed to solid execution rather than budget flushes, indicating a sustainable demand for their products.
• Hiring Strategy: Disciplined hiring is being guided by capital allocation priorities and efficiency improvements, particularly through AI initiatives.
• Competitive Positioning: Management expressed confidence in their competitive edge, emphasizing the importance of trust and established relationships in the sensitive data space.

This summary encapsulates the key points discussed during the earnings call, providing a clear overview of Cellebrite DI Ltd.'s performance and strategic direction.